CWM
ADPT icon

CIBC World Markets’s Adaptive Biotechnologies ADPT Stock Holding History

CIBC World Markets’s Portfolio ADPT Stock Details ADPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		$215K Sell
18,414
-7,286
-28% -$66.2K ﹤0.01% 1255
2025
Q1 		$191K Buy
25,700
+14,861
+137% +$114K ﹤0.01% 1488
2024
Q4 		$65K Buy
+10,839
New +$59.8K ﹤0.01% 1248

Other funds holding ADPT

Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

CIBC World Markets's ADPT Position: Q2 2025 in Review

CIBC World Markets reduced its Adaptive Biotechnologies (ADPT) stake by 28% in Q2 2025, selling an estimated $66.2K and leaving 18,414 shares worth $215K. The position accounts for ﹤0.01% of the portfolio, ranked #1255.

CIBC World Markets first reported a position in ADPT in Q4 2024 and has held it in 3 quarters since. 242 funds tracked by Wall St. Rank hold ADPT as of Q2 2025.

  • CIBC World Markets held 18,414 shares of Adaptive Biotechnologies worth $215K as of Q2 2025.
  • CIBC World Markets sold 7,286 Adaptive Biotechnologies shares in Q2 2025, an estimated $66.2K.
  • Adaptive Biotechnologies made up ﹤0.01% of CIBC World Markets's portfolio in Q2 2025, its #1255 holding.
  • CIBC World Markets first reported a position in Adaptive Biotechnologies in Q4 2024 and has held it in 3 quarters since.
  • 242 funds tracked by Wall St. Rank held Adaptive Biotechnologies as of Q2 2025.

Based on CIBC World Markets's 13F filing for Q2 2025, filed 14 Aug 2025.